openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 9
Nifedipine Extended-Release Tablets, 30 mg, 100-count bottles, Rx Only, Manufactured for Alvogen Inc. Pine Brook, NJ 07058 USA, NDC 47781-368-01.
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Code information
Lot #: BXH1P21A, Exp. 11/2017
Distribution pattern
Nationwide
drug · product 3 of 9
Adalat CC (nifedipine) Extended Release Tablets, 60 mg, 100- count bottles, Rx only Manufactured for Almatica, Almatica Pharma Inc. Pinebrook, NJ 07058 USA, NDC 50419-702-05
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Code information
Lot #: BXH1P51, BXH66D1, BXH1P51A, BXH5ZS1, Exp. 03/2018; BXH1P52, Exp. 05/2018; BXHBKF1A, and BXHB8S1A, Exp. 10/2018.
Distribution pattern
Nationwide
drug · product 6 of 9
Adalat CC (nifedipine) Extended-Release Tablets, 90 mg, 100-count bottles, Rx Only, Manufactured for Almatica Pharma Inc. Pine Brook, NJ 07058 USA, NDC 50419-70305
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Code information
Lot #: BXH66D1A, Exp. 03/2018
Distribution pattern
Nationwide
drug · product 7 of 9
Adalat CC (nifedipine) Extended-Release Tablets, 30 mg, 100-count bottles, Rx Only, Manufactured for Almatica Pharma Inc. Pine Brook, NJ 07058 USA, NDC 5242749401
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Code information
Lot #: BXHBJD1A, Exp. 10/2018
Distribution pattern
Nationwide
drug · product 8 of 9
Adalat CC (nifedipine) Extended-Release Tablets, 60 mg, 100-count bottles, Rx Only, Manufactured for Almatica Pharma Inc. Pine Brook, NJ 07058 USA, NDC 5242749501
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Code information
Lot #: BXCUE1A, Exp. 01/2019
Distribution pattern
Nationwide
drug · product 9 of 9
Adalat CC (nifedipine) Extended-Release Tablets, 90 mg, 100-count bottles, Rx Only, Manufactured for Almatica Pharma Inc. Pine Brook, NJ 07058 USA, NDC 5242749601
